Table of Contents

EBOLA: ESSENTIALS, RESPONSE EFFORTS, AND PREVENTION ISSUES; EBOLA: ESSENTIALS, RESPONSE EFFORTS, AND PREVENTION ISSUES; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: EBOLA: BASICS ABOUT THE DISEASE; THE EBOLA VIRUS AND EVD; TRANSMISSION; SYMPTOMS AND DIAGNOSIS; DEATH RATES; PREVENTING TRANSMISSION; THERAPIES AND VACCINES; OUTBREAK MODELS AND PROJECTIONS; Chapter 2: U.S. AND INTERNATIONAL HEALTH RESPONSES TO THE EBOLA OUTBREAK IN WEST AFRICA; SUMMARY; BACKGROUND; HEALTH SYSTEM CONSTRAINTS IN AFFECTED COUNTRIES; INTERNATIONAL HEALTH RESPONSES Chapter 7: STATEMENT OF JEH JOHNSON, SECRETARY, U.S. DEPARTMENT OF HOMELAND SECURITY. HEARING ON ''U.S. GOVERNMENT RESPONSE: FIGHTING EBOLA AND PROTECTING AMERICA''Chapter 8: EBOLA: SELECTED LEGAL ISSUES; SUMMARY; INTRODUCTION; PREVENTING SPREAD OF THE DISEASE; CIVIL RIGHTS; Chapter 9: FEDERAL AND STATE QUARANTINE AND ISOLATION AUTHORITY; SUMMARY; INTRODUCTION; FEDERAL AUTHORITY; STATE POLICE POWERS AND QUARANTINE AUTHORITY; LEGAL CHALLENGES TO QUARANTINE AUTHORITY; INDEX HISTORY OF NIAID EBOLA VIRUS RESEARCH: RELATIONSHIP TO BIODEFENSE RESEARCHDEVELOPMENT AND TESTING OF EBOLA MEDICAL COUNTERMEASURES; CLINICAL TRIALS TO EVALUATE EFFICACY; CONCLUSION; Chapter 6: STATEMENT OF SYLVIA BURWELL, SECRETARY, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. HEARING ON ''U.S. GOVERNMENT RESPONSE: FIGHTING EBOLA AND PROTECTING AMERICA''; HHS RESPONSE; EMERGENCY APPROPRIATIONS REQUEST; DOMESTIC PREPAREDNESS AND RESPONSE; INTERNATIONAL RESPONSE; VACCINES, THERAPEUTICS, AND DIAGNOSTICS; GLOBAL HEALTH SECURITY; CONCLUSION U.S. RESPONSES TO PANDEMIC THREATS AND EBOLAPOSSIBLE ISSUES FOR CONGRESS; CONCLUSION; Chapter 3: PREVENTING THE INTRODUCTION AND SPREAD OF EBOLA IN THE UNITED STATES: FREQUENTLY ASKED QUESTIONS; Chapter 4: STATEMENT OF DR. THOMAS R. FRIEDEN, DIRECTOR, CENTERS FOR DISEASE CONTROL AND PREVENTION. HEARINGON ''EXAMINING THE U.S. PUBLIC HEALTH RESPONSE TO THE EBOLA OUTBREAK''; Chapter 5: TESTIMONY OF DR. ANTHONY S. FAUCI, DIRECTOR, NATIONAL INSTITUTEOF ALLERGY AND INFECTIOUS DISEASES. HEARING ON ''EXAMINING THE U.S. PUBLIC HEALTH RESPONSE TO THE EBOLA OUTBREAK''; OVERVIEW OF EBOLA VIRUS DISEASE The Ebola virus is named after the Ebola River, near where the virus was discovered in 1976 in Zaire, now known as the Democratic Republic of the Congo (DRC). It is in the filovirus family, so called because of its filamentous shape. EVD is also known as Ebola hemorrhagic fever. The disease sometimes causes hemorrhage (i.e., bleeding) from body openings, but this symptom is not consistent. Five strains of Ebola virus have been identified. This book discusses the essentials, response efforts, and prevention issues involved with the Ebola virus.